Literature DB >> 25902808

Allergies and Disease Severity in Childhood Narcolepsy: Preliminary Findings.

Secil Aydinoz1, Yu-Shu Huang2, David Gozal1, Clara O Inocente3, Patricia Franco3, Leila Kheirandish-Gozal1.   

Abstract

INTRODUCTION: Narcolepsy frequently begins in childhood, and is characterized by excessive daytime sleepiness, with the presence of cataplexy reflecting a more severe phenotype. Narcolepsy may result from genetic predisposition involving deregulation of immune pathways, particularly involving T helper 2 cells (Th2). Increased activation of Th2 cells is usually manifested as allergic conditions such as rhinitis, atopic dermatitis, and asthma. We hypothesized that the presence of allergic conditions indicative of increased Th2 balance may dampen the severity of the phenotype in children with narcolepsy.
METHODS: A retrospective chart review of childhood narcolepsy patients was conducted at three major pediatric sleep centers. Patients were divided into those with narcolepsy without cataplexy (NC-) and narcolepsy with cataplexy (NC+). Demographics, polysomnographic and multiple sleep latency test data, and extraction of information on the presence of allergic diseases such allergic rhinitis, atopic dermatitis, and asthma was performed.
RESULTS: There were 468 children identified, with 193 children in NC- group and 275 patients in the NC+ group. Overall, NC+ children were significantly younger, had higher body mass index, and had shorter mean sleep latencies and increased sleep onset rapid eye movement events. The frequency of allergic conditions, particularly asthma and allergic rhinitis, was markedly lower in NC+ (58/275) compared to NC- patients (94/193; P < 0.0001).
CONCLUSION: Involvement of the immune system plays an important role in the pathophysiology of narcolepsy. Current findings further suggest that an increased shift toward T helper 2 cells, as indicated by the presence of allergic conditions, may modulate the severity of the phenotype in childhood narcolepsy, and reduce the prevalence of cataplexy in these patients.
© 2015 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  allergy; asthma; cataplexy; narcolepsy; sleep latency

Mesh:

Year:  2015        PMID: 25902808      PMCID: PMC4667389          DOI: 10.5665/sleep.5254

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  36 in total

Review 1.  The hypocretins and their role in narcolepsy.

Authors:  Daniel Kroeger; Luis de Lecea
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-08       Impact factor: 4.388

2.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

Authors:  E Mignot; R Hayduk; J Black; F C Grumet; C Guilleminault
Journal:  Sleep       Date:  1997-11       Impact factor: 5.849

3.  Genome-wide gene expression profiling of human narcolepsy.

Authors:  Camilla Bernardini; Wanda Lattanzi; Paolo Bosco; Christian Franceschini; Giuseppe Plazzi; Fabrizio Michetti; Raffaele Ferri
Journal:  Gene Expr       Date:  2012

4.  How age influences the expression of narcolepsy.

Authors:  Maurice M Ohayon; Luidgi Ferini-Strambi; Giuseppe Plazzi; Salvatore Smirne; Vincenza Castronovo
Journal:  J Psychosom Res       Date:  2005-12       Impact factor: 3.006

5.  Cases of pediatric narcolepsy after misdiagnoses.

Authors:  Shilpa R Kauta; Carole L Marcus
Journal:  Pediatr Neurol       Date:  2012-11       Impact factor: 3.372

Review 6.  Practice parameters for the non-respiratory indications for polysomnography and multiple sleep latency testing for children.

Authors:  R Nisha Aurora; Carin I Lamm; Rochelle S Zak; David A Kristo; Sabin R Bista; James A Rowley; Kenneth R Casey
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

Review 7.  Narcolepsy and immunity.

Authors:  E Mignot; M Tafti; W C Dement; F C Grumet
Journal:  Adv Neuroimmunol       Date:  1995

Review 8.  Narcolepsy in childhood.

Authors:  Sona Nevsimalova
Journal:  Sleep Med Rev       Date:  2009-01-18       Impact factor: 11.609

9.  AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.

Authors:  Hanna Nohynek; Jukka Jokinen; Markku Partinen; Outi Vaarala; Turkka Kirjavainen; Jonas Sundman; Sari-Leena Himanen; Christer Hublin; Ilkka Julkunen; Päivi Olsén; Outi Saarenpää-Heikkilä; Terhi Kilpi
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

10.  Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma.

Authors:  Deepa Rastogi; Sasha Fraser; Jamie Oh; Ashley M Huber; Yael Schulman; Renuka H Bhagtani; Zeeshan S Khan; Lydia Tesfa; Charles B Hall; Fernando Macian
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 30.528

View more
  7 in total

1.  Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features.

Authors:  Virginia Ponziani; Monia Gennari; Fabio Pizza; Antonio Balsamo; Filippo Bernardi; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

Review 2.  Sleep disorders in children with asthma.

Authors:  Joel Reiter; Maya Ramagopal; Alex Gileles-Hillel; Erick Forno
Journal:  Pediatr Pulmonol       Date:  2021-03-01

3.  The Association Between Asthma and Narcolepsy: A Nationwide Case-Control Study in Taiwan.

Authors:  Tien-Yu Chen; Vincent Yi-Fong Su; Chung-Hsin Lee; Chi-Hsiang Chung; Chia-Kuang Tsai; Chung-Kan Peng; Hsiao-Ching Lai; Wu-Chien Chien; Nian-Sheng Tzeng
Journal:  Nat Sci Sleep       Date:  2021-09-21

4.  Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases.

Authors:  Francisco J Martinez-Orozco; Miguel Fernandez-Arquero; Jose L Vicario; Laura Lillo-Triguero; Elena Ameyugo; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2022-08-27

5.  Factors Associated with Depression and Sub-Dimension Symptoms in Adolescent Narcolepsy.

Authors:  Yang Yang; Chenyang Li; Long Zhao; Jing Li; Fang Han; Fulong Xiao
Journal:  Nat Sci Sleep       Date:  2021-07-06

6.  Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.

Authors:  Francisco Javier Martinez-Orozco; Jose Luis Vicario; Clara De Andres; Miguel Fernandez-Arquero; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2016-05-29

7.  Concomitant atopic dermatitis and narcolepsy type 1: psychiatric implications and challenges in management.

Authors:  Justin Chin; Craig Bearison; Nanette Silverberg; Mary Lee Wong
Journal:  Gen Psychiatr       Date:  2019-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.